NDLI: Progress and obstacles in vaccine development for the ehrlichioses

Please wait, while we are loading the content...

Progress and obstacles in vaccine development for the ehrlichioses

Content Provider	PubMed Central
Author	Mcbride, Jere W. Walker, David H.
Copyright Year	2010
Abstract	Ehrlichia are tick-borne obligately intracellular bacteria that cause significant diseases in veterinary natural hosts, including livestock and companion animals, and are now considered important zoonotic pathogens in humans. Vaccines are needed for these veterinary and zoonotic human pathogens, but many obstacles exist that have impeded their development. These obstacles include understanding genetic and antigenic variability, influence of the host on the pathogen phenotype and immunogenicity, identification of the ehrlichial antigens that stimulate protective immunity and those that elicit immunopathology, development of animal models that faithfully reflect the immune responses of the hosts and understanding molecular host–pathogen interactions involved in immune evasion or that may be blocked by the host immune response. We review the obstacles and progress in addressing barriers associated with vaccine development to protect livestock, companion animals and humans against these host defense-evasive and cell function-manipulative, vector-transmitted pathogens.
Related Links	http://dx.doi.org/10.1586/erv.10.93
Ending Page	1082
Page Count	12
Starting Page	1071
File Format	PDF
ISSN	14760584
e-ISSN	17448395
Journal	Expert review of vaccines
Issue Number	9
Volume Number	9
Language	English
Publisher Date	2010-09-01
Access Restriction	Open
Subject Keyword	Immunology Molecular Medicine Pharmacology Drug Discovery Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Drug Discovery Pharmacology Immunology Molecular Medicine

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Middle East respiratory syndrome: obstacles and prospects for vaccine development

Progress in filovirus vaccine development: evaluating the potential for clinical use

The search for animal models for Lassa fever vaccine development

Anti-cocaine vaccine development

Novel vaccine development strategies for inducing mucosal immunity

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine

Respiratory syncytial virus vaccine development

Norovirus Vaccine Development –Next Steps

Development of hepatitis C virus vaccines: challenges and progress

Progress and obstacles in vaccine development for the ehrlichioses

Similar Documents

Middle East respiratory syndrome: obstacles and prospects for vaccine development

Progress in filovirus vaccine development: evaluating the potential for clinical use

The search for animal models for Lassa fever vaccine development

Anti-cocaine vaccine development

Novel vaccine development strategies for inducing mucosal immunity

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine

Respiratory syncytial virus vaccine development

Norovirus Vaccine Development –Next Steps

Development of hepatitis C virus vaccines: challenges and progress

Progress and obstacles in vaccine development for the ehrlichioses